BioSpace News Archive

Syndax Pharmaceuticals, Inc. today announced that Briggs W. Morrison , M.D., Chief Executive Officer of Syndax, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 08:15 a.m. ET.

AN2 Therapeutics, Inc. today announced several significant strides in the company’s development over the past year.

Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the H.C. Wainwright Bioconnect 2022 Virtual Conference.

Mersana Therapeutics, Inc. today provided its strategic priorities and anticipated milestones for 2022.

Icosavax, Inc. today provided a corporate update and shared anticipated milestones for 2022.

Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present virtually at the 40th Annual J.P. Morgan Healthcare Conference.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals, will present at the virtual H.C. Wainwright BioConnect Conference taking place January 10-13, 2022.

Kriya Therapeutics, Inc. announced today that it has acquired Warden Bio, a company developing novel AAV-mediated gene therapies for glycogen storage disorders (GSDs).

Dermavant Sciences today announced that new patient satisfaction data from PSOARING 3, the long-term extension study of tapinarof cream for the treatment of plaque psoriasis in adults, will be presented at the 2022 Winter Clinical Dermatology Conference, to be held Jan. 14-19 in Koloa, Hawaii.

USA Equities Corp. (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive value-based healthcare solutions through the use of emerging digital and point of care technologies, recently found additional scientific validation for its digital medicine platform -- QHSLab.